Zydus Lifesciences Quarterly Results

Charts

YoY Net Sales (Quarterly)

Operating Margin

EPS Growth

POSITIVES

NEGATIVES

Profit decreased by 10.23% compared to previous quarter.
Revenue decreased by 14.3% from last quarter, signaling potential demand issues.
High interest expense growth, which may pressure net profit margins.

Field	Mar 23	Jun 23	Sep 23	Dec 23	Mar 24	Jun 24	Sep 24	Dec 24	Mar 25	Jun 25
Revenue	5,010.60	5,139.60	4,368.80	4,505.20	5,533.80	6,207.50	5,237	5,269.10	6,527.90	6,573.70
Expenses	3,755	3,634.30	3,304.90	3,402.80	3,908.60	4,123.50	3,821	3,881.50	4,402.40	4,542.30
Operating Profit	1,255.60	1,505.30	1,063.90	1,102.40	1,625.20	2,084	1,416	1,387.60	2,125.50	2,031.40
Other Income	37.80	36	136.20	37.70	161.70	63.20	113.60	57.50	80.60	212
Interest	27.70	18.10	8.70	19.80	34.60	32.20	25.10	32	76.60	84.70
Depreciation	178.60	179.80	184.20	194.80	205.30	215.30	233.60	229	237.90	238.10
Profit Before Tax	497.60	1,350.70	1,030.60	981.90	1,564.10	1,918.60	1,293	1,206	1,666.90	1,955
Tax	137.20	216.10	226.40	213.80	321.20	436.10	373.10	179.50	423.20	434
Net Profit	358.20	1,133.60	803.20	789.90	1,246.10	1,482.50	920.20	1,026.20	1,243.70	1,521
Eps in Rs	2.93	10.74	7.91	7.80	11.69	14.11	9.06	10.17	11.64	14.58